In the life sciences, conferences and trade shows remain among the best strategies to expand your network, build partnerships, and drive growth.
But as anyone who has attended without a plan knows, your event presence can quickly be derailed, resulting in poor-quality prospects and conversations that go nowhere.
In this post, we share our business development team's top tips to make the most of your next event and transform those fleeting interactions into tangible business outcomes.
Read MoreLicensing is a critical growth lever for emerging biotechs. But crafting an effective licensing strategy requires foresight, a deep understanding of the landscape, and careful execution. We share our tips to help you secure your next licensing deal. in the biotech space.
Read MoreStrategic partnerships have become a cornerstone for growth, but for many companies the process of identifying, selecting, and formalizing an agreement with a partner can feel overwhelming. In this post, we break down how you can successfully form a strategic partnership in the pharmaceutical and biotech industries.
Read MoreArtificial intelligence (AI) continues to gain steam across the medical diagnostics space. In this post, we break down the most notable areas to watch in healthcare diagnostics that are being transformed by AI and machine learning (ML).
Read MoreNeed to set up a data room to provide to potential partners, investors, and other stakeholders? Download our free guidebook to learn best practices for preparing a data room to secure a successful deal in pharma and biotech.
Read MoreIn this post, we take a look at the top healthcare trends and future predictions for the women’s health space, including research areas, the femtech movement, and changing care pathways.
Read MoreCanada is an established leader in the life sciences, with a business landscape that’s promising but unique. Let’s take a look at the Canadian life sciences landscape, the benefits of doing business here, and key points that international companies should be aware of to ensure success.
Read MoreThe CNS sector presents a variety of opportunities for pharmaceutical companies of all sizes and stages given the complexity and prevalence of neurological disorders. Here are some key areas of opportunity, which you may find relevant as you consider your own pipeline.
Read MoreWhat does the future hold for the life science sector as we head into 2024?
Like years past, there was a continued blending of digital technologies with scientific advancement. A recent Deloitte report boiled it down to three key trends: digital transformation, generative AI, and adoption of digital health tools. In this post we explore each, as well as additional trends expected to share healthcare and life science innovation in the year to come.
Read More
